Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

NRC Group ASA - Appointed to a contract in Finland - EUR 3,9 million

Finnish Transport Infrastructure Agency (FTIA) has appointed NRC Group Finland, a company wholly owned by NRC Group ASA, to a contract for rail works on the railway connection between Helsinki and Riihimäki and at Järvenpää station. The contract is valued at approximately EUR 3,9 million. The work will commence in July 2023, and is scheduled for completion in December 2025. Closing date for submission of complaints is 14 days from today, and formal contractual signing can take place after this period at the earliest. For further information, please contact: Henning Olsen, CEO of

Vestas wins 45 MW order in Greece

News release from Vestas MediterraneanMadrid, 30 June 2023 EDF Renewables has placed a 45 MW order for the Karamoutzi and Karfoula wind parks, to be located in Viotia, Greece. The contract includes the supply and installation of ten V136-4.5 MW wind turbines, as well as a 4000 Active Output Management (AOM 4000) service agreement. “We are very proud to collaborate again with EDF Renewables. We pioneered wind energy in Greece together back in 1986. It is exciting to see how 37 years later we continue to contribute to the expansion of wind energy in the country with Vestas´ latest

Audientes: Bridge loan prolonged

Company Announcement 23-2023June 30, 2023 Audientes A/S (CVR 36047631) today announces that it has prolonged its existing bridge loan with existing lenders prior to a more long-term capital raise.Bridge loan prolonged: As another step in its capitalization plan, prior to a more long-term capital raise, Audientes today announces that it has prolonged an existing bridge loan from existing lenders until August 31, 2023.   The loan, with accumulated interest and earlier fees included, amounts to DKK 5.5 million at June 30th, 2023, and carries an interest rate of 2 percent per

Regarding mandatory offer from Axel Johnson AB

Dustin notes that Axel Johnson AB, through its wholly-owned subsidiary, AxMedia AB (”Axel Johnson”), on June 27, 2023 announced that Axel Johnson had acquired an additional 2,000,000 shares in Dustin Group AB (publ) (“Dustin”) and, thereafter, owns 30.5 percent of the shares and votes in Dustin. Thus, the threshold for making a mandatory public offer had been exceeded and on June 29, 2023, Axel Johnson announced such an offer of SEK 28.50 per share to the shareholders in Dustin (the “Offer”). The independent members of Dustin’s Board of Directors, Stina Andersson, Gunnel Duveblad, Morten

BioStock: New positive results for Curasight in brain cancer

Curasight’s recently announced preclinical results showed uTREAT’s potential in inhibiting glioblastoma growth. Adding to this milestone, the company has now also announced encouraging phase II results for uTRACE, demonstrating its prognostic value for survival outcomes in primary glioblastoma patients. BioStock contacted CEO Ulrich Krasilnikoff to learn more about what this means for the company.Read the full article at biostock.se: https://www.biostock.se/en/2023/06/new-positive-results-for-curasight-in-brain-cancer/ This is a press release from BioStock - Connecting Innovation &

Case Registered with the Swedish Companies Registration Office and Record Date for Consolidation of MyFirstApp Sweden AB's Shares

Press Release - 2023-06-30 At MyFirstApp Sweden AB (publ) Annual General Meeting on June 9 2023, it was decided in accordance with the board's proposal for a set-off issue in connection with the acquisition of 10Monkeys, which is now registered with the Swedish Companies Registration Office. The share capital amounts to a total of SEK 16,848,892.75 and the number of shares amounts to 3,369,778. At the Annual General Meeting, a decision was also made, in accordance with the Board's proposal, for a consolidation of 336,977,855 shares (reverse split), 1:100 by consolidating 100 shares

Kyoto Group AS – Minutes from the annual general meeting held on 30 June 2023

Oslo, Norway 30 June 2023 - Reference is made to the stock exchange announcements made by Kyoto Group AS (the "Company") on 22 June 2023 regarding the signing of a strategic investment agreement with Iberdrola and Spirax-Sarco Engineering and the notice of the Company's annual general meeting.The Company is pleased to announce that the general meeting adopted all the proposed resolutions with the requisite majority. Consequently, the Company is pleased to officially welcome Iberdrola and Spirax-Sarco Engineering as new shareholders. The minutes from the general meeting are attached to

Former Charter SVP Joe Godas joins Teleste’s Advisory Board for the North American market

Turku, FINLAND – 30 June 2023 – Teleste is delighted to announce that Joe Godas (former Charter Communications Senior Vice President Network Engineering & Technology) has joined the company’s Advisory Board  for the North American cable broadband market, which aims to support Teleste in expanding market opportunities for cable access networks. The nomination reflects Teleste’s commitment to strengthening its foothold and strategy as an access

BAKKAFROST: Share Savings Plan Transaction

As a part of the share savings plan for employees in 2023, the following primary insiders have purchased Bakkafrost shares: · Regin Jacobsen, CEO, purchased 77 shares. After the transaction, he holds 4,619.593 shares. · Høgni Dahl Jakobsen, CFO, purchased 54 shares. After the transaction, he holds directly and indirectly 76,445 shares. · Odd Eliasen, Managing Director, purchased 53 shares. After the transaction, he holds 186,581 shares. · Annika Frederiksberg, Board Member, purchased 21 shares. After the transaction, she holds directly and indirectly 16,731 shares. The

BioStock: Elicera gives an update in Cancer Immunotherapy Month

June is recognised globally as Cancer Immunotherapy Month, with the aim of shedding light on the role of immunotherapy in cancer. This type of treatment has revolutionised the field of oncology by extending the survival of cancer patients suffering from some of the deadliest cancers. In connection with Cancer Immunotherapy Month, BioStock contacted Elicera Therapeutics, a biotechnology company active in the field.Read the interview with Elicera Therapeutics at biostock.se:https://www.biostock.se/en/2023/06/elicera-gives-an-update-in-cancer-immunotherapy-month/This is a press release

Inside information: Nightingale Health and Terveystalo sign letter of intent to expand strategic partnership

Company release, Inside information 30 June 2023 at 11:20 a.m. (EEST)   Nightingale Health Plc (“Nightingale Health”), a technology company promoting preventative health with its proprietary health risk detection platform, and Suomen Terveystalo Oy (“Terveystalo”), Finland’s largest health service company, have signed a letter of intent to expand their strategic partnership. Nightingale Health expects that the expansion of the partnership will significantly increase the blood sample analysis volumes ordered by Terveystalo.   The letter of intent is a continuation of the

NYAB Oyj - Managers' Transactions

NYAB PlcMANAGERS' TRANSACTIONS30 June 2023 at 11:20NYAB Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Johan Larsson Position: Chief Executive Officer  Issuer: NYAB Oyj LEI: 743700UX7WTIOT3QO547 Notification type: INITIAL NOTIFICATION Reference number: 34181/4/4 ____________________________________________ Transaction date: 2023-06-29 Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME) Instrument type: SHARE ISIN: FI4000153515 Nature of transaction: ACQUISITION

VTT participates in two European Defence Fund projects that received a total of 58 million euros

The European Commission has announced the results of the 2022 research and development projects under the European Defence Fund (EDF). VTT Technical Research Centre of Finland is involved in two projects that received a total of EUR 58 million from the EU. They will help to develop the EU’s defence capabilities in critical areas in the pan-European air defence and in space-based military intelligence. The projects are led by Airbus Defence and Space.“The funding granted by the European Commission brings Europe together at this important time. It is of paramount importance for us to

Safello becomes the first Nordic platform to offer Circle’s euro-backed stablecoin

Stockholm, 30 June 2023 | Safello, the leading crypto exchange in the Nordics, today announced plans to list Euro Coin, Circle Internet Financial’s fully-reserved, euro-backed stablecoin. Safello’s focus on stablecoins has increased as the use cases have matured significantly. As the first Swedish platform to list Circle’s USDC, Safello is now following up by offering Euro Coin, or EUROC, to institutional clients.  Natively available on the Ethereum and Avalanche networks, Euro Coin has a circulation of over 47 million euros (as of June 29, 2023), according to CoinGecko 

Invitation to presentation of Pandox’s interim report January–June 2023

Pandox AB (publ) publishes its interim report for the period January–June 2023 on 14 July 2023, at 07:00 CEST, followed by a webcasted telephone conference at 08:30 CEST.Afterwards, a proprietary presentation on the international hotel market, separate from Pandox’s earnings presentation, will be held by Robin Rossmann, Managing Director, STR International. To follow the conference by phone, please use one of the following numbers:SE: +46 8 505 163 86UK: +44 20 319 84884US: +1 412 317 6300Pin code: 6992204# To follow the presentation via webcast, please use the following

Saab welcomes first T-7A Red Hawk flight by USAF pilot

The first flight by a United States Air Force’s (USAF) pilot of a T-7A advanced jet trainer built during the Engineering and Manufacturing Development (EMD) phase took place on June 28 from St. Louis, USA.The 63-minute flight by the USAF test pilot Maj. Bryce Turner, 416[th] Flight Test Squadron and Boeing T-7 chief test pilot Steve Schmidt, was observed by senior representatives of the USAF, Boeing, and Saab, as well as an audience who watched online via the internet. “The first flight of the T-7A by a serving Air Force pilot is a historic achievement for the program and is a tribute to

Q-Free: Invitation to presentation of Q2/H1 2023 results

Q-Free ASA will present its second quarter and first half results 2023 on Friday 7 July 2023 at 09.00 a.m. President & CEO Thale Kuvås Solberg and CFO Trond Christensen will represent the company. The live presentation will only be available through webcast. Language: English Webcast: The presentation will be broadcasted live through the following link: http://www.q-free.com/investor_relations/web-cast/ For webcast viewers, it will be possible to submit questions during the presentation. A recorded version of the presentation will also be available after the broadcast is

Kebni achieves ISO 9001 Certification for Quality Excellence

Kebni, Swedish tech company specializing in advanced products for stabilization, navigation, and Satcom, announces its attainment of ISO 9001 certification. This internationally recognized standard validates Kebni's commitment to delivering high-quality products and services while continuously improving internal processes.ISO 9001 establishes rigorous standards for organizations to establish and maintain effective quality management systems, ensuring consistent product and service quality, customer satisfaction, and continuous improvement. Kebni's achievement of this certification

OXC-101 as a novel therapy for AML will be presented at 18[th] Annual Congress of International Drug Discovery Science & Technology, Amsterdam 12-14 July, 2023

Oxcia’s CEO Ulrika Warpman Berglund has been invited to present “OXC-101: A Novel Way to Treat Acute Myeloid Leukemia by Inducing Mitotic Arrest, ROS and Oxidative Damage” at the 18[th] Annual Congress of International Drug Discovery Science & Technology (IDDST) conference, Amsterdam, the Netherlands, July 12-14, 2023. OXC-101 is a mitotic MTH1 inhibitor, with a unique synergistic dual mechanism of action. It arrests cancer cells in mitosis by disturbing microtubule polymerization, thereby accumulating ROS which in turn generates e.g. oxidized nucleotides. By inhibiting the enzyme MTH1,

Talkpool signs major contract with Germany’s leading operator

Talkpool’s German subsidiary Talkpool Deutschland AG has signed a five-year frame agreement with Germany’s leading telecommunications operator (the Company) for the design and planning of its German fixed broadband network. The value of the frame agreement is estimated to be about 17.5 million euros.The new contract further strengthens Talkpool’s growing market share in the German market, which is one of Talkpool’s strategic growth areas. Talkpool is an established player on the German telecom network services market and a trusted service partner of the Company, which is Germany’s as well

Change of number of shares and votes in Truecaller AB (publ)

The number of shares and the share votes in Truecaller AB (publ) (“Truecaller”) has changed during June 2023 as a result of the issue of C-shares to secure the company’s commitments under share program 2023. The class C shares will be converted to ordinary shares of series B in connection with the delivery of ordinary shares of series B under share program 2023. All C shares have been repurchased by the Company.As of 30 June 2023, the last trading day of June, the number of shares in Truecaller amounts to 379,559,710, of which 46,783,800 ordinary shares class A with 10 votes per share and

Change in number of shares and votes in Hufvudstaden

When the total number of shares or votes in the company changes, the company shall by law publish information regarding the change. At the 2001 Annual General Meeting, a share conversion clause was added to Hufvudstaden’s articles of association. Shareholders have the right at any time to request conversion of series C shares to series A shares. During the month of June 2023, 1,097 series C shares were converted to series A shares. Through the share conversion, the total number of votes in the company has decreased from 1,030,182,410 to 1,030,073,807 votes. The total number of

Petter Segelman Lindqvist appointed new CEO of Hamlet Pharma

Hamlet Pharma, soon to be Hamlet BioPharma, the innovative pharmaceutical company with several projects in Phase II trials in infection and cancer and an extensive project and patent portfolio, announces the appointment of Petter Segelman Lindqvist as new CEO, starting October 1[st] 2023.The recruitment of Petter Segelman Lindqvist marks a new phase in the development of Hamlet BioPharma’s groundbreaking technologies for cancer and infection therapy. Petter Segelman Lindqvist’s extensive experience from the global pharmaceutical Industry will increase the emphasis on partnering,

Invitation - presentation of Sandvik’s report of the second quarter 2023

Sandvik will publish its second quarter results on Wednesday, July 19, 2023 at approximately 11:30 AM CEST. A combined webcast and conference call for investors, analysts and financial media will be held at 1:00 PM CEST. The report will be presented in a webcast and conference call by Stefan Widing, President and CEO as well as by Cecilia Felton, CFO. The presentation will be broadcasted live on our website home.sandvik Dial-in details for the conference call: SE: +46 (0) 8 505 10 031 UK: +44 (0) 207 107 06 13 US: +1 (1) 631 570 56 13 From about 12:30 PM CEST

There are no items matching the current filter
There are no more items matching the current filter
Back to top